A First Time in Human (FTIH) Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK3884464 in Healthy Participants
Clinical trial NCT05044325 · TERMINATED
Trial details
- NCT number
- NCT05044325
- Sponsor
- GlaxoSmithKline
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-20
- Primary completion
- 2022-08-05
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.